Noble Capital Markets Emerging Growth Virtual Equity Conference 2025 – Presentation Replays

5/5/2025

Business

0 min read

Watch the replays from the Noble Capital Markets Emerging Growth Virtual Equity Conference. Replays are available to Channelchek registered members. Registration is free and easy. Simply click the Join button in the upper right to get started.

Day 1 Replays

**Connect Biopharma (CNTB)**
**Watch the Replay**

**Charles River Associates (CRAI)**
**Watch the Replay**

**Eledon Pharmaceuticals (ELDN)**
**Watch the Replay**

**Euroseas (ESEA)**
**Watch the Replay**

**The ONE Group (STKS)**
**Watch the Replay**

**Steelcase (SCS)**
**Watch the Replay**

**GoHealth (GOCO)**
**Watch the Replay**

**Unicycive Therapeutics (UNCY)**
**Watch the Replay**

**Townsquare Media (TSQ)**
**Watch the Replay**

**Greenwich LifeSciences (GLSI)**
**Watch the Replay**

**CBL International (BANL)**
**Watch the Replay**

**Twin Hospitality Group (TWNP)**
**Watch the Replay**

**Flushing Financial (FFIC)**
**Watch the Replay**

Day 2 Replays

**Sigma Lithium (SGML)**
**Watch the Replay**

**BioLargo Inc. (BLGO)**
**Watch the Replay**

**SKYX Platforms (SKYX)**
**Watch the Replay**

**Titan International (TWI)**
**Watch the Replay**

**Superior Group of Companies** **Watch the Replay**

**CoreCivic (CXW)**
**Watch the Replay**

**Brilliant Earth Group (BRLT)**
**Watch the Replay**

**Cocrystal Pharma (COCP)**
**Watch the Replay**

**Sky Harbour Group (SKYH)**
**Watch the Replay**

**FAT Brands (FAT)**
**Watch the Replay**

**Lottery.com (LTRY)**
**Watch the Replay**

**SBC Medical Group (SBC)**
**Watch the Replay**

**Kalaris Therpeutics (KLRS)**
**Watch the Replay**

**Nutriband (NTRB)**
**Watch the Replay**

Participating in 1×1 Meetings Only

Access to Exclusive Content. FREE for Registered Users Only.

Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.

‌

The site "channelcheck" is opened on the phone

Welcome to the Channelchek Investor Community

We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.

Don't have an account? Join

Forgot password

By clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.

Release MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings

MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that independent directors including Adelina Louie Ngar Yee and...

5 min read

‌

MariMed Inc (MRMD) – Rescheduling A Positive

12/24/2025

Cannabis

MariMed Inc (MRMD) – Rescheduling A Positive

Rescheduling. In what many are calling the single greatest cannabis reform in U.S. history with far-reaching benefits for years to come, President Trump signed an Executive Order to speed up the rescheduling...

2 min read

‌

Great Lakes Dredge & Dock (GLDD) – Another Pause for Offshore Wind

12/24/2025

Uncategorized

Great Lakes Dredge & Dock (GLDD) – Another Pause for Offshore Wind

Another Pause. The Trump Administration is pausing leases for five offshore wind projects, including the Sunrise Wind and Empire Wind 1 projects, both of which Great Lakes’ soon to be delivered Acadia vessel...

3 min read

‌

Comstock (LODE) – Rating Lowered to Market Perform from Outperform

12/24/2025

Basic Materials

Comstock (LODE) – Rating Lowered to Market Perform from Outperform

Rating Lowered to Market Perform. While we had upgraded Comstock Inc. to Outperform on November 4, we have concluded our rating upgrade may have been too early, despite the share price...

3 min read

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

NewsMorning ResearchVideos

By clicking submit you are agreeing to the Terms of Use and Privacy Policy